Baird Maintains Outperform on Snowflake, Raises Price Target to $215

Over the past 3 months, 4 analysts have published their opinion on Treace Medical Concepts (NASDAQ:TMCI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.